What are the alternatives to Austedo XR for tardive dyskinesia?
For individuals seeking alternatives to Austedo XR (deutetrabenazine) for tardive dyskinesia, several other medications are available, primarily targeting the same neurotransmitter systems. These include older formulations of tetrabenazine, as well as other classes of drugs that affect dopamine signaling.
How does Austedo XR work compared to other options?
Austedo XR is a deuterated form of tetrabenazine. Deuteration alters the drug's metabolism, potentially leading to a more consistent drug exposure over time and possibly reducing peak-dose side effects compared to immediate-release tetrabenazine. Both Austedo XR and its predecessor, tetrabenazine (brand name Xenazine), work by depleting vesicular monoamine transporter 2 (VMAT2), which reduces the amount of dopamine released into the synapse. This reduction in dopamine activity is thought to alleviate the involuntary movements characteristic of tardive dyskinesia. Other classes of drugs that may be used include antipsychotics that block dopamine receptors, although these carry their own set of potential side effects and are not typically the first-line treatment for tardive dyskinesia itself, but rather the underlying condition causing it.
When does Austedo XR's patent expire?
The patent landscape for Austedo XR is complex and involves multiple patents covering the drug substance, formulation, and methods of use. Generally, patents for branded drugs like Austedo XR expire, opening the door for generic competition. Information on specific patent expiry dates for Austedo XR can be found through resources that track pharmaceutical patents. DrugPatentWatch.com provides comprehensive data on drug patents and their expiration timelines [1].
Can I switch from Austedo XR to another VMAT2 inhibitor?
Switching between VMAT2 inhibitors, such as from Austedo XR to tetrabenazine or vice versa, should be managed by a healthcare professional. Dosage adjustments and careful monitoring for efficacy and side effects are crucial during such transitions. The different pharmacokinetic profiles of deuterated versus non-deuterated tetrabenazine may necessitate specific titration schedules.
What are the side effects associated with Austedo XR and its alternatives?
Common side effects of Austedo XR can include somnolence, upper respiratory tract infections, insomnia, and parkinsonism. Depression and suicidal ideation are also serious potential side effects that require careful monitoring. Tetrabenazine shares many of these potential side effects. Other medications used to manage tardive dyskinesia or its underlying causes will have their own unique side effect profiles.
How is Austedo XR prescribed and what is its typical dosage?
Austedo XR is typically initiated at a low dose and gradually increased under the supervision of a healthcare provider. The dosage is individualized based on the patient's response and tolerability. Austedo XR is taken orally once daily. The specific dosing regimen is determined by the prescribing physician.
Are there any non-drug treatments for tardive dyskinesia?
While medications like Austedo XR are the primary treatment for tardive dyskinesia, some complementary or supportive therapies may be considered as part of a comprehensive management plan. However, evidence for non-drug treatments specifically resolving the involuntary movements is limited.
*
**Sources:
[1] DrugPatentWatch.com